ArticleThe World Allergy Organization journal2026
Comparison of dominant foodborne and inhalant allergies developing in the first 5 years of life.
Article in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: During the first 5 years of life, atopic individuals may develop cutaneous or respiratory symptoms with foodborne or airborne allergens. The route and dose of exposure are associated with sensitization. However, limited studies compare food and airborne allergies in these children. Objective: To characterize and compare the developmental patterns of symptoms, specific IgE (sIgE)/specific IgG4 (sIgG4), and B cell subsets in response to food or airborne allergens under 5 years old. Methods: Children aged from birth to 5 years old with food allergy and/or respiratory allergy symptoms were recruited from Jan 2019 to Dec 2021. Clinical parameters were systematically documented, and the sIgE responses to 29 common allergens were quantified via ImmunoCAP. A subset of participants (n = 45, with 9 cases in each age group) underwent assessments of sIgE/sIgG4 to egg, milk, and house dust mite (HDM) components. Peripheral B cell subsets were phenotypically characterized using multiparametric flow cytometry (n = 20). Results: As the children ages, positivity rate to inhalant allergens ( Conclusions: Our study demonstrates the frequency, route, and dosage of exposure may contribute to distinct variations in the repertoire of allergen-specific IgE/IgG antibodies and B cell subsets, highlighting the importance of exposure modalities in shaping early immune responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.